Paylocity Holding Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Paylocity Holding Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.60B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $1.40B | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $1.17B | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $852.65M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $635.63M | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | $130.59M | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | $171.65M | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | $132.37M | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | $126.72M | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | $120.37M | Aug 7, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.47B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $1.28B | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $1.10B | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $847.69M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $631.73M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $546.21M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $447.75M | Aug 6, 2021 |
| FY2020 | Jun 30, 2018 | $368.43M | Aug 7, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.10B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $960.79M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $807.56M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $565.65M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $416.33M | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | $84.71M | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | $123.57M | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | $86.95M | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | $84.09M | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | $80.28M | Aug 7, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $227.13M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $206.77M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $140.82M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $90.78M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $70.82M | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | $4.95M | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | $40.13M | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | $5.47M | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | $13.91M | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | $10.24M | Aug 7, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $304.02M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $260.09M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $155.03M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $84.59M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $58.04M | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | $6.32M | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | $47.74M | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | $6.11M | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | $6.00M | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | $9.21M | Aug 7, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $205.85M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $178.33M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $163.99M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $102.91M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $76.71M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $62.77M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $50.33M | Aug 6, 2021 |
| FY2020 | Jun 30, 2018 | $37.65M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $29.10M | Aug 9, 2019 |
| FY2018 | Jun 30, 2016 | $26.74M | Aug 10, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $418.23M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $384.67M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $282.72M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $155.05M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $124.85M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $112.66M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $115.03M | Aug 6, 2021 |
| FY2020 | Jun 30, 2018 | $97.87M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $61.98M | Aug 9, 2019 |
| FY2018 | Jun 30, 2016 | $32.99M | Aug 10, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.07M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $18.03M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $21.91M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $18.07M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $9.46M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $16.58M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $11.28M | Aug 6, 2021 |
| FY2020 | Jun 30, 2018 | $21.68M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $21.34M | Aug 9, 2019 |
| FY2018 | Jun 30, 2016 | $16.08M | Aug 10, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.39B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $4.25B | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $3.70B | Aug 2, 2024 |
| FY2023 | Jun 30, 2022 | $4.81B | Aug 4, 2023 |
| FY2022 | Jun 30, 2021 | $2.41B | Aug 5, 2022 |
| FY2021 | Jun 30, 2020 | $1.99B | Aug 6, 2021 |
| FY2020 | Jun 30, 2019 | $1.80B | Aug 7, 2020 |
| FY2019 | Jun 30, 2018 | $1.51B | Aug 9, 2019 |
| FY2018 | Jun 30, 2017 | $1.14B | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $1.39B | Aug 11, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.16B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $3.21B | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $2.85B | Aug 2, 2024 |
| FY2023 | Jun 30, 2022 | $4.20B | Aug 4, 2023 |
| FY2022 | Jun 30, 2021 | $1.94B | Aug 5, 2022 |
| FY2021 | Jun 30, 2020 | $1.59B | Aug 6, 2021 |
| FY2020 | Jun 30, 2019 | $1.50B | Aug 7, 2020 |
| FY2019 | Jun 30, 2018 | $1.29B | Aug 9, 2019 |
| FY2018 | Jun 30, 2017 | $989.83M | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $1.27B | Aug 11, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.23B | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $1.03B | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $842.86M | Aug 6, 2025 |
| FY2025 | Jun 30, 2022 | $613.46M | Aug 6, 2025 |
| FY2024 | Jun 30, 2021 | $476.93M | Aug 2, 2024 |
| FY2023 | Jun 30, 2020 | $392.91M | Aug 4, 2023 |
| FY2022 | Jun 30, 2019 | $307.96M | Aug 5, 2022 |
| FY2021 | Jun 30, 2018 | $212.82M | Aug 6, 2021 |
| FY2020 | Jun 30, 2017 | $147.61M | Aug 7, 2020 |
| FY2019 | Jun 30, 2016 | $119.57M | Aug 9, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $343.10M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $108.94M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $102.05M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $101.95M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $33.65M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $21.66M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $9.59M | Aug 6, 2021 |
| FY2019 | Jun 30, 2018 | $9.59M | Aug 9, 2019 |
| FY2018 | Jun 30, 2017 | $6.00M | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $6.00M | Aug 11, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $900.58M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $673.46M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | $466.69M | Aug 2, 2024 |
| FY2023 | Jun 30, 2022 | $325.87M | Aug 4, 2023 |
| FY2022 | Jun 30, 2021 | $235.09M | Aug 5, 2022 |
| FY2021 | Jun 30, 2020 | $164.27M | Aug 6, 2021 |
| FY2020 | Jun 30, 2019 | $99.82M | Aug 7, 2020 |
| FY2020 | Jul 1, 2018 | $45.99M | Aug 7, 2020 |
| FY2019 | Jun 30, 2018 | ($6.68M) | Aug 9, 2019 |
| FY2018 | Jun 30, 2017 | ($45.28M) | Aug 10, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $398.07M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $401.81M | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | $288.77M | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | $139.76M | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | $202.29M | Aug 4, 2023 |
| FY2022 | Jun 30, 2020 | $250.85M | Aug 5, 2022 |
| FY2021 | Jun 30, 2019 | $132.48M | Aug 6, 2021 |
| FY2020 | Jun 30, 2018 | $137.19M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $103.47M | Aug 9, 2019 |
| FY2018 | Jun 30, 2016 | $86.50M | Aug 10, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $162.50M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | $0 | Aug 6, 2025 |
| FY2021 | Jun 30, 2020 | $100.00M | Aug 6, 2021 |
| FY2014 | Jun 30, 2013 | $1.56M | Aug 22, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 4 | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | 2 | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 7, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 4 | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Aug 6, 2025 |
| FY2025 | Jun 30, 2023 | 2 | Aug 6, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 2, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Aug 4, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 7, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 7, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 7, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 7, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 7, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 55.37M | Aug 6, 2025 |
| FY2025 | Jun 30, 2024 | 55.51M | Aug 6, 2025 |
| FY2024 | Jun 30, 2023 | 55.91M | Aug 2, 2024 |
| FY2023 | Jun 30, 2022 | 55.19M | Aug 4, 2023 |
| FY2022 | Jun 30, 2021 | 54.59M | Aug 5, 2022 |
| FY2021 | Jun 30, 2020 | 53.79M | Aug 6, 2021 |
| FY2020 | Jun 30, 2019 | 53.08M | Aug 7, 2020 |
| FY2019 | Jun 30, 2018 | 52.76M | Aug 9, 2019 |
| FY2018 | Jun 30, 2017 | 51.74M | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | 51.13M | Aug 11, 2017 |